Hamilton, Bermuda
Covidien Ltd. (NYSE: COV; BSX: COV) held its first Annual General Meeting as an independent, publicly held company. Two proposals were on the meeting agenda:
-- Election of Directors, and
-- Appointment of Independent Auditors.
At the meeting, shareholders elected all 11 nominees, each of whom currently serves on Covidien's Board of Directors. They are: Craig Arnold, Robert H. Brust, John M. Connors, Jr., Christopher J. Coughlin, Timothy M. Donahue, Kathy J. Herbert, Randall J. Hogan, III, Richard J. Meelia, Dennis H. Reilley, Tadataka Yamada, and Joseph A. Zaccagnino.
Shareholders also approved the appointment of Deloitte & Touche LLP to serve as the Company's independent auditors.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
Source: Business Wire (Business Wire India)